To amend section 5167.12 and to enact sections 3902.65, 4729.362, and 5164.093 of the Revised Code regarding prescription drug readers for visually impaired patients.
Summary
HB374 would require pharmacies and other licensed terminal distributors of dangerous drugs to provide notice that a prescription reader is available before selling a prescription drug, and to furnish a prescription reader when requested by a blind or visually impaired patient or someone purchasing on that patient’s behalf. The device must audibly convey the information required on the prescription label, including cautions, drug interactions, contraindications, and side effects, and the pharmacy must ensure the container label is compatible with the reader. The bill also creates a parallel Medicaid coverage requirement for these prescription readers.
In addition to the new consumer-access provisions, the bill amends Medicaid managed care rules to preserve existing limits on prior authorization for certain antidepressants and antipsychotics, while reaffirming the Department of Medicaid’s authority to require prior authorization for controlled substances through pharmacy utilization management programs. The prescription-reader coverage provisions would apply to health benefit plans issued or renewed in Ohio on or after the effective date, and the Medicaid coverage mandate would apply within the state Medicaid program.
Impact
The bill would add new sections to the Revised Code governing pharmacy dispensing practices, private health benefit plan coverage, and Medicaid coverage for prescription readers. It would require retail pharmacies, mail-order pharmacies, and other covered distributors to provide notice and access to assistive reading devices for visually impaired patients, while exempting certain institutional, government, correctional, and drug repository pharmacies, and preserving existing drug-labeling laws. It would also require Medicaid to cover these devices and would make conforming changes to Medicaid managed care administration under section 5167.12.
Sentiment
The bill appears to have a generally supportive, accessibility-focused purpose, with its core policy aimed at improving prescription access for blind and visually impaired patients. Because the bill was only introduced and there are no recorded committee transcripts or votes in the provided materials, there is no documented public debate or formal legislative sentiment beyond the bill’s apparent bipartisan-style sponsorship and broad cosponsorship list.
Contention
The main policy questions likely concern implementation and cost: pharmacies would need to provide compatible readers and notices, and insurers and Medicaid would have to cover the devices. Potential points of contention include whether the mandate should apply to all pharmacies or only certain settings, how compatibility and reader functionality would be defined in practice, and whether the coverage requirement could increase costs for health plans, Medicaid, or pharmacies. The bill also preserves existing Medicaid prior-authorization authority for controlled substances, which may reflect an effort to balance access with utilization control.